Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides

Human Molecular Genetics

Volumn 7, Issue 7, 1998, Pages 1083-1090

  Dunckley, Matthew G ^a,d   Manoharan, Muthiah ^b   Villiet, Pierre ^b   Eperon, Ian C ^c   Dickson, George ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b ISIS PHARMACEUTICALS   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; DYSTROPHIN; OLIGORIBONUCLEOTIDE;

ANIMAL CELL; ARTICLE; BECKER MUSCULAR DYSTROPHY; CELL CULTURE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE THERAPY; GENETIC TRANSFECTION; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MYOTUBE; NONHUMAN; NONSENSE MUTATION; OPEN READING FRAME; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOLEMMA;

ANIMALS; CELL NUCLEUS; CELLS, CULTURED; DYSTROPHIN; EXONS; GENE EXPRESSION; INTRONS; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; OLIGONUCLEOTIDES, ANTISENSE; POINT MUTATION; POLYETHYLENEIMINE; RNA SPLICING; SARCOLEMMA; TRANSFECTION;

EID: 0031800293     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.7.1083     Document Type: Article

References (56)

1. Hoffman, E.P., Brown, R.H. and Kunkel, L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
2. Koenig, M. et al. (1989) The molecular basis for Duchenne versus Backer muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet., 45, 498-506.
3. Monaco, A.P., Bertelson, C.J., Liechti-Gallati, S., Moser, H. and Kunkel, L.M. (1988) An explanation for phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics, 2, 90-95.
4. England, S.B., Nicholson, L.V.B., Johnson, M.A., Forrest, S.M., Love, D.R., Zubrzycka-Gaarn, E.E., Bulman, D.E., Harris, J.B. and Davies, K.E. (1990) Very mild muscular dystrophy associated with deletion of 46% of dystrophin. Nature, 343, 180-182.
5. Morandi, L., Mora, M., Bemasconi, P., Mantegazza, R., Gebbia, M., Balestrini, M.R. and Cornelio, F. (1993) Very small dystrophin molecule in a family with a mild form of Becker dystrophy. Neuromusc. Disorders, 3, 65-70.
6. Nicholson, L.V.B., Johnson, M.A., Bushby, K.M.D. and Gardner-Medwin, D. (1992) Functional significance of dystrophin-positive fibres in Duchenne muscular dystrophy. Arch. Dis. Child., 68, 632-636.
7. Wells, D.J., Wells, K.E., Asante, E.A.,Turner, G., Sunada, Y., Campbell, K.P., Walsh, F.S. and Dickson, G. (1995) Expression of human full-length and minidystrophin in transgenic max mice: implications for gene therapy of Duchenne muscular dystrophy. Hum. Mol. Genet., 4, 1245-1250.
8. Sherratt, T.G., Vulliamy, T., Dubowitz, V., Sewry, C.A. and Strong, P.N. (1993) Exon skipping and translation in patients with frameshift deletions in the dystrophin gene. Am. J. Hum. Genet., 53, 1007-1015.
9. Thanh, L.T., Man, N.T., Helliwell, T.R. and Morris, G.E. (1995) Characterisation of revenant muscle fibres in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Am. J. Hum. Genet., 56, 725-731.
10. Wilton, S.D., Dye, D.E. and Laing, N.G. (1997) Dystrophin gene transcripts skipping the mdx mutation. Muscle Nerve, 20, 728-734.
11. Dunckley, M.G., Wells, D.J., Walsh, F.S. and Dickson, G. (1993) Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet., 2, 717-723.
12. Fassati, A., Wells, D.J., Serpente, P.A.S., Walsh, F.S., Brown, S.C., Strong, P.N. and Dickson, G. (1997) Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult mdx mouse via transplantation of retroviral producer cells. J. Clin. Invest., 100, 620-628.
13. Vincent, N. et al. (1993) Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet., 5, 130-134.
14. Trivedi, R.A. and Dickson, G. (1995) Liposome-mediated dystrophin gene transfer. J. Neurochem., 64, 2230-2238.
15. Ahn, A.H. and Kunkel, L.M. (1993) The structural and functional diversity of dystrophin. Nature Genet., 3, 283-291.
16. Rojanasakul, Y. (1996) Antisense oligonucleotide therapeutics: drug delivery and targeting. Adv. Drug Delivery Rev., 18, 115-131
17. Kozarsky, K.F. and Couture, L.A. (1997) Message therapy: gene therapy that targets mRNA sequence and stability. Am. J. Hum. Genet., 61, 790-794.
18. Helene, C. and Toulme, J.J. (1990) Specific regulation of gene expression by antisense, sense, and antigene nucleic acids. Biochim. Biophys. Acta, 1049, 99-125.
19. Mayeda, A., Hayase, Y., Inoue, H., Ohtsuka, E. and Ohshima, Y. (1990) Surveying cis-acting sequences of pre-messenger RNA by adding antisense 2′-O-methyl oligoribonucleotides to a splicing reaction. J. Biochem., 108, 399-405.
20. Wang, S. and Kool, E.T. (1995) Relative stabilities of triple helices composed of combinations of DNA, RNA, and 2′-O-methyl RNA backbones: chimeric circular oligonucleotides as probes. Nucleic Acids Res., 23, 1157-1164.
21. Dominski, Z. and Kole, R. (1993) Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc. Natl Acad. Sci. USA, 90, 8673-8677.
22. Takeshima, Y., Nishio, H., Sakamoto, H., Nakamura, H. and Matsuo, M. (1995) Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe. J. Clin. Invest., 95, 515-520.
23. Sierakowska, H., Sambade, M.J., Agrawal, S. and Kole, R. (1996) Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides. Proc. Natl Acad. Sci. USA, 93, 12840-12844.
24. Pramono, Z.A.D., Takeshima, Y., Alimsardjono, H., Ishii, A., Takeda, S. and Matsuo, M. (1996) Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence. Biochem. Biophys. Res. Commun., 226, 445-449.
25. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G. and Barnard, P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science, 244, 1578-1580.
26. Boussif, O., Lezonalc'h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B., and Behr, J.-P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine. Proc. Natl Acad. Sci. USA, 92, 7297-7301.
27. Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J.-P. and Demeneix, B.A. (1996) A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethyleneimine. Hum. Gene Ther., 7, 1947-1954.
28. Dodds, E., Dunckley, M.G., Naujoks, K., Michaelis, U. and Dickson, G. (1998) Lipofection of cultured mouse muscle cells: a direct comparison of Lipofectamine and DOSPER. Gene Ther., 5, 542-551.
29. Monia, B.P. et al. (1996) Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human c-raf kinase supports an antisense mechanism of action in vivo. Proc. Natl Acad. Sci. USA, 93, 15481-15484.
30. Bennett, C.F., Chiang, M.-Y., Chan, H., Shoemaker, J.E.E. and Mirabelli, C.K. (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol., 41, 1023-1033.
31. Lewis, J.G., Lin, K.-Y., Kathavale, A., Flanagan, W.M., Matteucci, M.D., DePrince, R.B., Mook, R.A., Hendren, R.W. and Wagner, R.W. (1996) A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl Acad. Sci. USA, 93, 3176-3181.
32. Monia, B.P., Lesnik, E.A., Gonzalez, C., Lima, W.F., McGee, D., Guinosso, C.J., Kawasaki, A.M., Cook, P.D. and Freier, S.M. (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem., 268, 14514-14522.
33. Cummins, L.L., Owens, S.R., Risen, L.M., Lesnik, E.A., Freier, S.M., McGee, D., Guinosso, C.J. and Cook, P.D. (1995) Characterisation of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridisation and nuclease sensitivity. Nucleic Acids Res., 23, 2019-2024.
34. Altmann, K.H. et al. (1996) Second generation of antisense oligonucleotides: from nuclease resistance to biological efficacy in animals. Chimia, 50, 168-176.
35. Zhang, R., Lu, Z., Zhang, X., Zhao, H., Diasio, R.B., Liu, T., Jiang, Z. and Agrawal, S. (1995) In vivo stability and disposition of a self-stabilised oligodeoxynucleotide phosphorothioate in rats. Clin. Chem., 41, 836.
36. Altmann, K.-H., Fabbro, D., Dean, N.M., Geiger, T., Monia, B.P., Mueller, M. and Nicklin, P. (1996b) Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal transduction inhibitors. Biochem. Soc. Trans., 24, 630-637.
37. Beltinger, C. et al. (1995) Binding, uptake and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin. Invest., 95, 1814-1823.
38. Baker, B.F., Lot, S., Condon, T.P., Cheng-Flourney, S., Lesnik, E., Sasmor, H. and Bennett, C.F. (1997) 2′-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level by formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem., 272, 11994-12000.
39. Griffey, R.H., Lesnik, E., Freier, S., Sanghvi, Y.S., Teng, K., Kawasaki, A., Guinosso, C. and Cook, P.D. (1996) In Sanghvi, Y.S. and Cook, P.D. (eds), Carbohydrate Modifications in Antisense Research, ACS Symposium Series 580. American Chemical Society, Washington, DC, pp. 212-224.
40. Crooke, S.T. et al. (1996) Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J. Pharmacol. Exp. Ther., 277, 923-937.
41. Manoharan, M., Tivel, K.L., Andrade, L.K. and Cook, P.D. (1995) 2′-O- and 3′-O-pyrimidine aminoether-containing oligonucleotides: synthesis and conjugation chemistry. Tetrahedron Lett., 36, 3647-3650.
42. Cooper, D.N. and Krawczak, M. (1993) Human Gene Mutation. Bios, Oxford.
43. Tennyson, C.N., Klamut, H.J. and Worton, R.G. (1995) The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nature Genet., 9, 184-190.
44. Nordstrom, J.L., Roop, D.R., Tsai, M.J. and O'Malley, B.W. (1979) Identification of potential ovomucoid mRNA precursors in chick oviduct nuclei. Nature, 278, 328-331.
45. Danko, I., Chapman, V. and Wolff, J.A. (1992) The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediat. Res., 32, 128-131.
46. Zhao, J., Yoshioka, K., Miike, T. and Miyatake, M. (1993) Developmental studies of dystrophin-positive fibers in mdx, and DRP localisation. J. Neurol. Sci., 114, 104-108.
47. Milner, N., Mir, K.U. and Southern, E.M. (1997) Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nature Biotechnol., 15, 537-541.
48. Chelly, J. et al. (1990) Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell, 63, 1239-1248.
49. Maquat, L.E. (1996) Defects in RNA splicing and the consequences of shortened translational reading frames. Am. J. Hum. Genet., 59, 279-286.
50. Tennyson, C.N., Shi, Q. and Worton, R.G. (1996) Stability of the human dystrophin transcript in muscle. Nucleic Acids Res., 24, 3059-3064.
51. Pegoraro, E. et al. (1995) Genetic and biochemical normalisation in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei. Neurology, 45, 677-690.
52. Allamand, V. et al. (1997) Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2 chain. Hum. Mol. Genet., 6, 747-752.
53. Dunckley, M.G., Eperon, I.C. and Dickson, G. (1997) Modulation of splicing in the DMD gene using antisense oligoribonucleotides. Nucleosides Nucleotides, 16, 1665-1668.
54. Walsh, F.S. and Ritter, M.A. (1981) Surface antigen differentiation during human myogenesis in culture. Nature, 289, 60-64.
55. Dunckley, M.G., Davies, K.E., Walsh, F.S., Morris, G.E. and Dickson, G. (1992) Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEBS Lett., 296, 128-134.
56. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.